Navigation Links
Lhasa Limited Announces the Acquisition of Granary Wharf House
Date:1/2/2014

LEEDS, England, January 2, 2014 /PRNewswire/ --

Leeds-based not-for-profit and educational charity Lhasa Limited acquires new headquarters

Lhasa Limited, a leading global supplier of knowledge-based software and associated databases for use in toxicity, metabolism and the related sciences, today announces the purchase of Granary Wharf House, Leeds, as its new international Headquarters. This investment provides the space necessary to ensure that Lhasa continues to meet its members' needs and its charitable purpose for the foreseeable future.

Lhasa Limited was incorporated as a charity with only one employee more than 30 years ago and was initially based in the chemistry department at the University of Leeds serving a small number of primarily UK-based chemical companies. Since then Lhasa has grown to a truly international member-based organisation with over 250 members with operations in the UK, Poland and the USA. Throughout this growth Lhasa has remained true to its founding principle of Shared Knowledge, Shared Progress.

In 2005 Lhasa Limited moved to its current headquarters in Blenheim Terrace, Leeds and since then, through the growing success of its world leading in silico prediction systems and its investment in research, Lhasa has more than doubled its work force.  

Granary Wharf House is situated in Granary Wharf, Leeds, an established business location that has benefitted from significant investment in recent years. Just a stone's throw from Leeds train station and the city centre the move will enhance Lhasa's links to the international community whilst retaining its strong academic relationship with the University of Leeds. Lhasa intends to start operations from Granary Wharf on Monday the 1st of March 2014.

Lhasa Limited's CEO said, "Lhasa's remarkable growth is testament to the commitment of its scientific staff and our drive to provide value to its members and through this, benefit to the public. Our investment in Granary Wharf House will ensure that Lhasa continues to meet its member needs and charitable purpose for the next 30 years and beyond."

About Lhasa Limited

Lhasa Limited is a not-for-profit organisation that facilitates collaborative data sharing projects in the pharmaceutical, cosmetics and chemistry-related industries. A pioneer in the production of knowledge-based systems for forward thinking scientists, Lhasa limited continues to draw on over thirty years of experience to create user-friendly, state of the art in silico prediction and database systems.

We believe in 'Shared Knowledge, Shared Progress'. Our not-for-profit, member driven status is designed to facilitate collaborative working and confidential data sharing between organisations. We run collaborative projects with industry, academia and regulatory bodies to continually enhance all our products.

Lhasa's products include Derek Nexus and Sarah Nexus for predicting toxicity, Vitic Nexus for managing chemical information, Meteor Nexus for predicting metabolic fate and Zeneth for predicting forced degradation pathways.

Contact:
Matthew Lord
+44(0)113-394-6091


'/>"/>
SOURCE Lhasa Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future of Treatment for Chronic Lymphocytic Leukemia
2. Ansell Limited To Acquire BarrierSafe Solutions International
3. Juvederm Special Offered for a Limited Time by Dr. Peyman Ghasri, Los Angeles Dermatologist
4. Plastic Surgeon Dr. Marc J. Salzman Announces Use of Astanza Trinity Laser Tattoo Removal System, Runs Limited-Time Promotion
5. Amerigen Pharmaceuticals Limited today announced it had entered into a collaboration agreement with Forest Laboratories Inc. regarding the development of a number of specialty generic products.
6. Medicare Policies Restricting Power Wheelchair Repairs Leave Vulnerable Beneficiaries with Limited Mobility
7. Bureau Veritas Announces Sargam Laboratory Private Limited Name Change
8. FREE lice zapping comb for a limited time only at CVS
9. Body Wraps By It Works Now Only $59 For Loyal Customers: Limited Time Only
10. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
11. Pfenex Inc. and Agila Biotech Private Limited Announce Joint Venture to Develop Biosimilar Products for the Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):